334 related articles for article (PubMed ID: 11058925)
1. Response of blood pressure to maximum exercise in hypertensive patients under different therapeutic programs.
de Queiroz Carreira MA; Ribeiro JC; Caldas JA; Tavares LR; Nani E
Arq Bras Cardiol; 2000 Oct; 75(4):281-8. PubMed ID: 11058925
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
[TBL] [Abstract][Full Text] [Related]
3. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
4. Current status of antihypertensive prescription and associated blood pressure control in Japan.
Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S
Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
[TBL] [Abstract][Full Text] [Related]
5. [Influence of risk factors and pharmacological treatment on mortality in patients with essential hypertension].
Román O; Cuevas G; Bunout D
Rev Med Chil; 1998 Jul; 126(7):745-52. PubMed ID: 9830766
[TBL] [Abstract][Full Text] [Related]
6. [Antihypertensive therapy in 357 inpatients of elderly isolated systolic hypertension].
Zhai LH; Yang CY; Jiang KW; Xu XY; Lu HZ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):719-22, 725. PubMed ID: 16708819
[TBL] [Abstract][Full Text] [Related]
7. The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure.
Schelleman H; Klungel OH; Witteman JC; Hofman A; van Duijn CM; de Boer A; Stricker BH
Eur J Hum Genet; 2006 Jul; 14(7):860-6. PubMed ID: 16724011
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive persistence and drug class.
Marentette MA; Gerth WC; Billings DK; Zarnke KB
Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
[TBL] [Abstract][Full Text] [Related]
9. Exercise-induced modifications in cardiorespiratory parameters of hypertensive patients treated with calcium antagonists.
Fariello R; Boni E; Corda L; Muiesan ML; Agabiti-Rosei E
J Hypertens Suppl; 1991 Dec; 9(3):S67-72. PubMed ID: 1686784
[TBL] [Abstract][Full Text] [Related]
10. A comparison of four primary classes of antihypertensive monotherapy in Thai patients.
Sukonthasarn A
J Med Assoc Thai; 2000 Oct; 83(10):1202-10. PubMed ID: 11143486
[TBL] [Abstract][Full Text] [Related]
11. [Epidemiology of hypertension in the elderly population of Spain].
Banegas Banegas JR
An R Acad Nac Med (Madr); 2002; 119(1):143-52; discussion 153-9. PubMed ID: 12197202
[TBL] [Abstract][Full Text] [Related]
12. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
[TBL] [Abstract][Full Text] [Related]
14. The quality of arterial hypertension treatment in cardiology service in Kosovo--a single center study.
Bajraktari G; Sylejmani X; Thaçi K; Elezi S; Ndrepepa G
Anadolu Kardiyol Derg; 2009 Apr; 9(2):96-101. PubMed ID: 19357050
[TBL] [Abstract][Full Text] [Related]
15. Additional small amounts of diuretics improve blood pressure control at low cost without disadvantages in blood sugar metabolism.
Kudoh T; Nagawaga T; Nakagawa I
Hypertens Res; 2008 Mar; 31(3):455-62. PubMed ID: 18497464
[TBL] [Abstract][Full Text] [Related]
16. [Arterial hypertension and cardiac decompensation].
Degaute JP
Rev Med Brux; 1996 Sep; 17(4):272-4. PubMed ID: 8927860
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
18. Effect of HMG-CoA reductase inhibitors on blood pressure in hypertensive patients treated with blood pressure-lowering agents: retrospective study using an anti-hypertensive drug database.
Hashimoto S; Urushihara H; Hinotsu S; Kosugi S; Kawakami K
Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):235-41. PubMed ID: 22428476
[TBL] [Abstract][Full Text] [Related]
19. [Effects of calcium antagonist, angiotensin-converting enzyme inhibitors and beta-blocker on hemodynamic and sympathetic nerve responses to exercise in essential hypertension].
Fujiwara S; Arita M; Ueno Y; Shiotani M; Nakatsu C; Nakamura Y; Hano T; Nishio I; Masuyama Y
J Cardiol; 1991; 21(1):115-24. PubMed ID: 1687786
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacological hypertension therapy].
Pedersen OL; Christensen KL; Bang LE; Ibsen H; Schultz-Larsen P
Ugeskr Laeger; 2009 Jun; 171(24):2022-5. PubMed ID: 19523367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]